An HIV breakthrough is here. Let's not let it go to waste

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...
Hosted on MSN

Lenacapavir approved by FDA: What it means for HIV prevention

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
EurekAlert!

Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents

Despite many oral, once daily, medications for treatment for adolescents with Human Immunodeficiency Virus (HIV), many ...

Q Care Plus Expands Telehealth Access for Hair Loss, Birth Control, and Erectile Dysfunction Medications

Q Care Plus, a telehealth provider known for its leadership in providing HIV prevention and treatment and sexual wellness care, today announced the addition of treatment for erectile dysfunction (ED), ...
Medscape

Which Regimen Works Best for Late-Diagnosis HIV Care?

Researchers conducted a retrospective, multinational study across 15 European treatment centers to assess the efficacy and tolerability of DTG/3TC vs BIC/TAF/FTC as first‑line therapy in ...
Business Wire

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment ...